ARF6 and hepatocellular carcinoma: In this study, we conclude that ARF6 could enhance the proliferation and growth of HCC cells through activating STAT3 signaling pathway, which suggests that ARF6 may serve as potential prognostic and therapeutic targets for HCC patients.